Accelerating advancements in cancer prevention and cures, Wei Gao, assistant professor of pharmacology at the University of Houston College of Pharmacy, has received a $900,000 grant from the Cancer ...

Treating acute myeloid leukemia (AML) depends on knowing what goes wrong inside cells. A new study suggests that two genetic ...

Intrapleural enzyme therapy (IET) improves outcomes in adult inpatients with complicated parapneumonic pleural effusion or empyema.

Amgen Inc. has acquired cancer drug developer Dark Blue Therapeutics Ltd. in a deal worth as much as $840 million, expanding ...

Researchers are targeting dormant tumour cells that might explain why some cancers reappear long after successful treatment.

Recent advances in cancer biology have revealed that refractory malignancies, such as castration-resistant prostate cancer, pancreatic ductal ...

Immune checkpoint molecules play a crucial role in keeping the immune system in balance and preventing an attack on the ...

Rybrevant Faspro, the new subcutaneous version of amivantamab, was approved for patients with a specific form of lung cancer ...

Official websites use .mil A .mil website belongs to an official U.S. Department of Defense organization in the United States ...

One of the most challenging moments in cancer treatment comes when a therapy stops working. In many metastatic cancers, drugs ...

Postoperative complications, particularly those of an infectious and inflammatory nature, remain a critical factor impeding patient recovery and influencing ...

New research exposes MMS as a toxic disinfectant, not a cure. Scientists warn its risks far outweigh any claimed benefits.